Stock 002900 HARBIN MEDISAN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Harbin Medisan Pharmaceutical Co., Ltd.

Equities

002900

CNE1000032V9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
9.14 CNY +3.16% Intraday chart for Harbin Medisan Pharmaceutical Co., Ltd. -12.70% -33.04%
Apr. 26 Medisan Pharma's Potassium Chloride Injection Passes Drug Regulator's Evaluation MT
Apr. 25 Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

HARBIN MEDISAN PHARMACEUTICAL CO LTD is a China-based company principally engaged in the research and development, production and sales of chemical preparations, active pharmaceutical ingredients (APIs), medical devices and cosmetics. Its medicines cover the nervous system, cardio-cerebrovascular, systemic anti-infection, musculoskeletal, nutritional infusion, and body fluid balance infusion therapeutic fields. The Company's products include freeze-dried powder injections, small volume injections, large infusion products, solid preparations, medical devices and cosmetics. The Company mainly distributes its products within domestic market.

Number of employees: 2,115

Sales per Business

CNY in Million2022Weight2023Weight Delta
Large Transfusion
30.0 %
247 24.0 % 356 30.0 % +44.47%
Freeze Dried Powder Injection
25.1 %
348 33.9 % 298 25.1 % -14.51%
Solid Preparation
19.3 %
252 24.5 % 229 19.3 % -9.00%
Small Volume Injection
14.8 %
109 10.6 % 176 14.8 % +61.10%
Import and Export Trade
6.6 %
40 3.9 % 79 6.6 % +96.60%
Other Business
2.9 %
20 2.0 % 34 2.9 % +68.22%
Veterinary Medicine
0.8 %
1 0.1 % 9 0.8 % +1,215.72%
Raw Material
0.4 %
11 1.0 % 5 0.4 % -55.68%
Functional Food
0.0 %
- - 1 0.0 % -
Medical Device
0.0 %
1 0.1 % 0 0.0 % -30.99%
Feed Additive
0.0 %
0 0.0 % 0 0.0 % +16.89%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
93.4 %
988 96.1 % 1,108 93.4 % +12.11%
Overseas
6.6 %
40 3.9 % 79 6.6 % +96.60%

Managers

Managers TitleAgeSince
Jian Fei Qin CEO
 Chief Executive Officer 61 13-12-23
Zhi Cheng Zhao DFI
 Director of Finance/CFO 49 21-03-04
Dan Fei Liang BRD
 Director/Board Member 57 13-12-23

Members of the board

Members of the board TitleAgeSince
Fu Sheng Wang BRD
 Director/Board Member 60 19-12-17
Hongquan Liu BRD
 Director/Board Member 65 22-03-16
Jian Fei Qin CEO
 Chief Executive Officer 61 13-12-23
Guo Min Zhu Ge BRD
 Director/Board Member 59 13-12-23
Li Zhou BRD
 Director/Board Member 62 13-12-23
Dan Fei Liang BRD
 Director/Board Member 57 13-12-23
Guo Lin Zeng BRD
 Director/Board Member 45 20-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 316,390,050 105,818,350 ( 33.45 %) 4,293,369 ( 1.357 %) 33.45 %

Shareholders

NameEquities%Valuation
China Asset Management Co., Ltd.
0.8680 %
1,434,100 0.8680 % 2 M ¥
Broad Fund Management Co. Ltd.
0.1093 %
180,500 0.1093 % 247 263 ¥
Gfund Management Co., Ltd.
0.1062 %
175,500 0.1062 % 240 414 ¥
Western Leadbank Fund Management Co., Ltd
0.0876 %
144,700 0.0876 % 198 222 ¥
China Southern Asset Management Co., Ltd.
0.0369 %
61,000 0.0369 % 83 563 ¥
Fullgoal Fund Management Co., Ltd.
0.0139 %
23,000 0.0139 % 31 507 ¥
Penghua Fund Management Co., Ltd.
0.008413 %
13,900 0.008413 % 19 041 ¥
Guotai Asset Management Co., Ltd.
0.000424 %
700 0.000424 % 959 ¥
NameEquities%Valuation
Dan Fei Liang
0.4173 %
631,600 0.4173 % 865 216 ¥
Zhi Cheng Zhao
0.0661 %
100,000 0.0661 % 136 988 ¥

Holdings

NameEquities%Valuation
HARBIN FUERJIA TECHNOLOGY CO., LTD.
4.97%
 18,000,000 4.97% 85,979,340 $

Company contact information

Harbin Medisan Pharmaceutical Co., Ltd.

Beijing Road Limin Development Zone

150025, Harbin

+

http://www.medisan.com.cn
address Harbin Medisan Pharmaceutical Co., Ltd.(002900)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
HARBIN MEDISAN PHARMACEUTICAL CO., LTD. Stock Harbin Medisan Pharmaceutical Co., Ltd.
-33.04% 390M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+45.82% 765B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.95% 632B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.16% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.86% 331B
ABBVIE INC. Stock AbbVie Inc.
+9.32% 299B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.45% 248B
ROCHE HOLDING AG Stock Roche Holding AG
-0.78% 219B
NOVARTIS AG Stock Novartis AG
+11.88% 216B
AMGEN INC. Stock Amgen Inc.
+5.90% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002900 Stock
  4. Company Harbin Medisan Pharmaceutical Co., Ltd.